Hong Jun Liang

Director/Board Member at BEIJING STRONG BIOTECHNOLOGIES,INC.

50 year

Health Technology

Health Services

Profile

Hong Jun Liang is currently the Vice Chairman at Beijing Strong Biotechnologies, Inc. and Director at Fuzhou Maixin Biotech Co., Ltd.
Previously, he served as the Chairman-Supervisory Board at Shanghai Shyndec Pharmaceutical Co., Ltd.
and as a Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
from 2018 to 2020.

Hong Jun Liang active positions

Companies	Position	Start
BEIJING STRONG BIOTECHNOLOGIES,INC.	Director/Board Member	2020-08-12
Fuzhou Maixin Biotech Co., Ltd. Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang.	Director/Board Member	2020-09-14

All active positions of Hong Jun Liang

Former positions of Hong Jun Liang

Companies	Position	End
JIANGSU HENGRUI MEDICINE CO., LTD.	Director/Board Member	2019-12-31
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Chairman	2019-11-14

See the detail of Hong Jun Liang's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hong Jun Liang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
JIANGSU HENGRUI MEDICINE CO., LTD.	Health Technology
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Health Technology
BEIJING STRONG BIOTECHNOLOGIES,INC.	Health Technology

Private companies	1
Fuzhou Maixin Biotech Co., Ltd. Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang.	Health Services